Related Experiment Video
Updated: Apr 27, 2026
07:32
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
11.0K
Noncovalent interaction-assisted polymeric micelles for controlled drug delivery
Jianxun Ding1, Linghui Chen, Chunsheng Xiao
1Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, P. R. China. xschen@ciac.ac.cn.
Chemical Communications (Cambridge, England)
|July 10, 2014
Summary
Polymeric micelles are advanced nanocarriers for drug delivery. Noncovalent interactions enhance their stability and function, showing promise for controlled drug release and clinical applications.
Area of Science:
- Nanotechnology and Materials Science
- Biomedical Engineering
- Pharmaceutical Sciences
Background:
- Polymeric micelles are key nanocarriers for drug delivery.
- Their physical stability and functionality are crucial for therapeutic efficacy.
- Noncovalent interactions offer novel strategies to improve micelle performance.
Purpose of the Study:
- To review diverse noncovalent interactions used in polymeric micelle design.
- To highlight advancements in using these interactions for drug nanocarriers.
- To discuss future directions and perspectives in this field.
Main Methods:
- Review of literature on noncovalent interactions in polymeric micelles.
- Analysis of various interaction types: hydrophobic, electrostatic, host-guest, hydrogen bonding, stereocomplex, and coordination.
- Examination of micelle stability, intelligence, and bioactivity enhancement.
Main Results:
- Noncovalent interactions significantly improve polymeric micelle physical stability.
- These interactions can impart specific intelligences and bioactivities to micelles.
- Many noncovalent-mediated micelles show great potential for controlled drug delivery.
- Some advanced micelles have progressed to clinical trials.
Conclusions:
- Noncovalent interactions are versatile tools for engineering advanced polymeric micelles.
- These engineered micelles hold significant promise for next-generation drug delivery systems.
- Further research into noncovalent-mediated micelles is expected to yield innovative therapeutics.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
156
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
156
01:24Modified-Release Drug Delivery Systems: Site-Targeted
161
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
161
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
01:23Modified-Release Drug Delivery Systems: Classification
309
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
309
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
170
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
170